Medapp

Medapp Equity Ratio

The Equity Ratio of Medapp (MDA.WA) as of Nov 20, 2026 is 47.68 %. In the previous year, Equity Ratio was 55.24 % — a change of -13.69% (lower).

Equity Ratio

47.68 %

YoY

-13.69%

Last updated:

Equity Ratio of Medapp is 2025 47.68 % . Equity Ratio of Medapp was 2024 55.24 % . It decreases by -13.69% lower compared to the previous year.

The Medapp Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
44.61 PLN
Jan 1, 2019
86.54 PLN
Jan 1, 2020
88.54 PLN
Jan 1, 2021
77.73 PLN
Jan 1, 2022
84.61 PLN
Jan 1, 2023
67.29 PLN
Jan 1, 2024
55.24 PLN
Jan 1, 2025
47.68 PLN
The Medapp Equity Ratio history
YEAREquity RatioYoY
47.68 %-13.69%
55.24 %-17.91%
67.29 %-20.47%
84.61 %+8.85%
77.73 %-12.21%
88.54 %+2.31%
86.54 %+94.00%
44.61 %-27.20%
61.28 %-8.87%
67.24 %-28.79%
94.43 %-219.21%
-79.21 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medapp Stock analysis

What does Medapp do? MedApp SA generates revenue through its mobile marketing solutions in the medical field, primarily via the Carna Life software application. Carna Life functions as a telemedicine platform enabling doctors and patients to communicate, with features including data upload and download for test results, offline data review, and graphical statistics. The company serves healthcare providers and patients seeking telemedicine services, focusing on the Polish market through its Krakow headquarters. Moonrock Enterprise SA controls MedApp SA, leveraging its software for medical communication solutions. The firm's revenue model centers on the Carna Life application, which provides telemedicine services by facilitating secure data exchange between doctors and patients. Patients use the app to upload test results, while doctors interpret them through the platform, supported by offline functionality and data visualization tools. This system targets medical professionals and patients in Poland, operating within the telemedicine sector without external partnerships or additional branded products. MedApp SA's business relies solely on the Carna Life telemedicine system, which offers both online and offline modes for data management. The application includes statistics, visualizations, and tables for interpreted medical data, serving as a communication channel between healthcare providers and patients. Controlled by Moonrock Enterprise SA, the company monetizes its software through direct sales to medical institutions and patient users in the Polish healthcare market. Medapp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medapp stock

Equity Ratio of Medapp is 47.68 % in 2025.

Equity Ratio of Medapp changed from 55.24 % to 47.68 %, representing a -13.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Medapp since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Medapp with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Medapp

All Key Metrics — Medapp